New research published in the Proceedings of the National Academy of Sciences on March 25 suggests that when individuals’ minds…
Read More
First Phase 3 psilocybin data clears the bar for treatment-resistant depression, but how high was the bar?
For decades, the medical community has grappled with the persistent challenge of mood disorders, offering successive waves of antidepressants that,…
Read More
First Phase 3 psilocybin data clears the bar for treatment-resistant depression, but how high was the bar?
The landscape of mental health treatment witnessed a significant development on February 17, 2026, as Compass Pathways, a leading mental…
Read More
Researchers Identify Cellular Energy Deficits as Key Biological Marker for Early Stage Major Depression
In a collaborative breakthrough that may redefine the clinical understanding of psychiatric disorders, researchers from the University of Queensland and…
Read MoreYOU MAY HAVE MISSED
